カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のヒトマイクロバイオーム治療市場2020-2024

◆英語タイトル：Global Human Microbiome Therapeutics Market 2020-2024
◆商品コード：IRTNTR43730
◆発行会社（リサーチ会社）：Technavio
◆発行日：2020年5月27日
◆ページ数：約120
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、その他
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥260,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥312,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥416,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートではヒトマイクロバイオーム治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別（胃腸疾患、免疫学的症状、その他）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・ヒトマイクロバイオーム治療の世界市場：用途別（胃腸疾患、免疫学的症状、その他）
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Human Microbiome Therapeutics Market 2020-2024

Technavio has been monitoring the human microbiome therapeutics market and it is poised to grow by USD 276.93 mn during 2020-2024 progressing at a CAGR of 15% during the forecast period. Our reports on human microbiome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic diseases and robust pipeline. In addition, growing prevalence of chronic diseases is anticipated to boost the growth of the market as well.

The human microbiome therapeutics market analysis includes application segment and geographic landscapes
Technavio’s human microbiome therapeutics market is segmented as below:
By Application
• Gastrointestinal disorders
• Immunological conditions
• Others

By Geographic Landscapes
• North America
• Europe
• APAC
• ROW

This study identifies the side effects of existing treatment as one of the prime reasons driving the human microbiome therapeutics market growth during the next few years.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our human microbiome therapeutics market covers the following areas:
• Human microbiome therapeutics market sizing
• Human microbiome therapeutics market forecast
• Human microbiome therapeutics market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human microbiome therapeutics market vendors that include Bristol-Myers Squibb Co., Dow Inc., ENTEROME SA, Ferring Pharmaceuticals AS, Johnson & Johnson, Kaleido Biosciences Inc., PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the human microbiome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-human-microbiome-therapeutics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Gastrointestinal disorders – Market size and forecast 2019-2024
o Immunological conditions – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Bristol-Myers Squibb Co.
o Dow Inc.
o ENTEROME SA
o Ferring Pharmaceuticals AS
o Johnson & Johnson
o Kaleido Biosciences Inc.
o PureTech Health Plc
o Second Genome Therapeutics
o Seres Therapeutics Inc.
o Takeda Pharmaceutical Co. Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Gastrointestinal disorders – Market size and forecast 2019-2024 ($ million)
• 24: Gastrointestinal disorders – Year-over-year growth 2019-2024 (%)
• 25: Immunological conditions – Market size and forecast 2019-2024 ($ million)
• 26: Immunological conditions – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by Application
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: APAC – Market size and forecast 2019-2024 ($ million)
• 38: APAC – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Bristol-Myers Squibb Co. – Overview
• 50: Bristol-Myers Squibb Co. – Business segments
• 51: Bristol-Myers Squibb Co. – Key offerings
• 52: Bristol-Myers Squibb Co. – Key customers
• 53: Bristol-Myers Squibb Co. – Segment focus
• 54: Dow Inc. – Overview
• 55: Dow Inc. – Business segments
• 56: Dow Inc. – Key offerings
• 57: Dow Inc. – Key customers
• 58: Dow Inc. – Segment focus
• 59: ENTEROME SA – Overview
• 60: ENTEROME SA – Product and service
• 61: ENTEROME SA – Key offerings
• 62: ENTEROME SA – Key customers
• 63: ENTEROME SA – Segment focus
• 64: Ferring Pharmaceuticals AS – Overview
• 65: Ferring Pharmaceuticals AS – Product and service
• 66: Ferring Pharmaceuticals AS – Key offerings
• 67: Ferring Pharmaceuticals AS – Key customers
• 68: Ferring Pharmaceuticals AS – Segment focus
• 69: Johnson & Johnson – Overview
• 70: Johnson & Johnson – Business segments
• 71: Johnson & Johnson – Key offerings
• 72: Johnson & Johnson – Key customers
• 73: Johnson & Johnson – Segment focus
• 74: Kaleido Biosciences Inc. – Overview
• 75: Kaleido Biosciences Inc. – Product and service
• 76: Kaleido Biosciences Inc. – Key offerings
• 77: Kaleido Biosciences Inc. – Key customers
• 78: Kaleido Biosciences Inc. – Segment focus
• 79: PureTech Health Plc – Overview
• 80: PureTech Health Plc – Business segments
• 81: PureTech Health Plc – Key offerings
• 82: PureTech Health Plc – Key customers
• 83: PureTech Health Plc – Segment focus
• 84: Second Genome Therapeutics – Overview
• 85: Second Genome Therapeutics – Product and service
• 86: Second Genome Therapeutics – Key offerings
• 87: Second Genome Therapeutics – Key customers
• 88: Second Genome Therapeutics – Segment focus
• 89: Seres Therapeutics Inc. – Overview
• 90: Seres Therapeutics Inc. – Product and service
• 91: Seres Therapeutics Inc. – Key offerings
• 92: Seres Therapeutics Inc. – Key customers
• 93: Seres Therapeutics Inc. – Segment focus
• 94: Takeda Pharmaceutical Co. Ltd. – Overview
• 95: Takeda Pharmaceutical Co. Ltd. – Product and service
• 96: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 97: Takeda Pharmaceutical Co. Ltd. – Key customers
• 98: Takeda Pharmaceutical Co. Ltd. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Bristol-Myers Squibb Co., Dow Inc., ENTEROME SA, Ferring Pharmaceuticals AS, Johnson & Johnson, Kaleido Biosciences Inc., PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., Takeda Pharmaceutical Co. Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[世界のヒトマイクロバイオーム治療市場2020-2024]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 世界の抗菌治療市場2020-2024
    IRTNTR43391 / Technavio / 2020年5月2日 / 本調査レポートでは抗菌治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別（抗ウイルス性、抗菌性、抗真菌性、駆虫性）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・抗菌治療の世界市場：用途別（抗ウイルス性、抗菌性、抗真菌性、駆虫性） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Antimicrobial Therapeutics Market 2020-2024 Technavio has been monitoring the antimicrobial therapeutics market and it is poised to grow by $ 42.30 million during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the recent drug approvals and robust pipeline, initiatives from government agencies,...
  2. 世界の神経障害疼痛治療市場2020-2024
    IRTNTR43322 / Technavio / 2020年4月20日 / 本調査レポートでは神経障害疼痛治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、適応別（糖尿病性神経障害、化学治療-神経因性疼痛含む、帯状疱疹後神経痛、その他）分析、薬物クラス別（カルシウムチャネルアルファ2デルタリガンド、SNRI、TCA、オピオイド鎮痛薬、その他）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・神経障害疼痛治療の世界市場：適応別（糖尿病性神経障害、化学治療-神経因性疼痛含む、帯状疱疹後神経痛、その他） ・神経障害疼痛治療の世界市場：薬物クラス別（カルシウムチャネルアルファ2デルタリガンド、SNRI、TCA、オピオイド鎮痛薬、その他） ・顧客状況 ・地域別状況 ・企業状況...Global Neuropathy Pain Treatment Market 2020-2024 Technavio has been monitoring the neuropathy pain treatment market and it is poised to grow by $ 1702.89 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our reports on neuropathy pain treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the presence of large patient pool and focus...
  3. 世界のRSウイルス(RSV)診断市場2020-2024
    IRTNTR43463 / Technavio / 2020年4月23日 / 本調査レポートではRSウイルス(RSV)診断の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（消耗品、システム）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・RSウイルス(RSV)診断の世界市場：製品別（消耗品、システム） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Respiratory Syncytial Virus Diagnostics Market 2020-2024 Technavio has been monitoring the respiratory syncytial virus diagnostics market and it is poised to grow by $ 585.17 million during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on respiratory syncytial virus diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in product launches,...
  4. 世界の抗炎症治療市場2020-2024
    IRTNTR41324 / Technavio / 2020年3月24日 / 本調査レポートは抗炎症治療の世界市場について調査・分析し、エグゼクティブサマリー、市場環境、市場規模、ファイブフォース分析、顧客状況、地域別状況、市場の要因と課題、企業状況、企業分析などを含め、次の構成でお届けいたします。 ・エグゼクティブサマリ ・市場環境 ・市場規模 ・ファイブフォース分析 ・顧客状況 ・地域別状況 ・市場の要因・課題 ・企業状況 ・企業分析...Global Anti-Inflammatory Therapeutics Market 2020-2024 Technavio has been monitoring the global anti-inflammatory therapeutics market 2020-2024 and it is poised to grow by USD 27.53 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on global anti-inflammatory therapeutics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of imid. In addition,...
  5. 世界の整形外科用デバイス市場2020-2024
    IRTNTR43597 / Technavio / 2020年5月4日 / 本調査レポートでは整形外科用デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（整形外科用インプラント・支援機器、オーソバイオロジクス）分析、用途別（脊椎、膝、四肢、腰、CMF）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・整形外科用デバイスの世界市場：製品別（整形外科用インプラント・支援機器、オーソバイオロジクス） ・整形外科用デバイスの世界市場：用途別（脊椎、膝、四肢、腰、CMF） ・顧客状況 ・地域別状況 ・企業状況...Global Orthopedic Device Market 2020-2024 Technavio has been monitoring the orthopedic device market and it is poised to grow by $ 6.07 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on orthopedic device market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the target population with orthopedic disorders, trauma, and...
  6. 世界のPARP（ポリADPリボースポリメラーゼ）阻害薬市場2020-2024
    IRTNTR43323 / Technavio / 2020年5月2日 / 本調査レポートではPARP（ポリADPリボースポリメラーゼ）阻害薬の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別（卵巣癌、乳癌、その他）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・PARP（ポリADPリボースポリメラーゼ）阻害薬の世界市場：エンドユーザー別（卵巣癌、乳癌、その他） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2020-2024 Technavio has been monitoring the parp (Poly ADP-ribose Polymerase) inhibitors market and it is poised to grow by $ 810.23 million during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on parp (Poly ADP-ribose Polymerase) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the expanded application...
  7. 世界の心臓超音波検査(ECG)デバイス市場2020-2024
    IRTNTR43415 / Technavio / 2020年4月28日 / 本調査レポートでは心臓超音波検査(ECG)デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（安静時、外来、負荷）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・心臓超音波検査(ECG)デバイスの世界市場：製品別（安静時、外来、負荷） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Echocardiography Devices Market 2020-2024 Technavio has been monitoring the echocardiography devices market and it is poised to grow by $ 1.89 billion during 2020-2024 progressing at a CAGR of 7% during the forecast period. Our reports on echocardiography devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased incidence of cardiac disorders, focus on preventive treatment and...
  8. 世界の腹腔鏡デバイス市場2020-2024
    IRTNTR43678 / Technavio / 2020年5月27日 / 本調査レポートでは腹腔鏡デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（器具・部品、腹腔鏡）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・腹腔鏡デバイスの世界市場：製品別（器具・部品、腹腔鏡） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Laparoscopic Devices Market 2020-2024 Technavio has been monitoring the laparoscopic devices market and it is poised to grow by USD 3.92 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. Our reports on laparoscopic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing popularity of MI techniques and the growing geriatric...
  9. 世界のフローダイバージョン動脈瘤治療市場2020-2024
    IRTNTR43691 / Technavio / 2020年5月27日 / 本調査レポートではフローダイバージョン動脈瘤治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（FDS、脳動脈瘤用塞栓デバイス）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・フローダイバージョン動脈瘤治療の世界市場：製品別（FDS、脳動脈瘤用塞栓デバイス） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Flow Diversion Aneurysm Treatment Market 2020-2024 Technavio has been monitoring the flow diversion aneurysm treatment market and it is poised to grow by $ 1.64 bn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the preference for flow...
  10. 世界のオートクレーブ市場2020-2024
    IRTNTR43584 / Technavio / 2020年5月4日 / 本調査レポートではオートクレーブの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別（医療施設・診断研究所、学術研究機関）分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・市場状況 ・市場規模 ・ファイブフォース分析 ・オートクレーブの世界市場：エンドユーザー別（医療施設・診断研究所、学術研究機関） ・顧客状況 ・地域別状況 ・企業状況 ・企業分析...Global Autoclave Market 2020-2024 Technavio has been monitoring the autoclave market and it is poised to grow by $ 468.13 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on autoclave market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for autoclave equipment to prevent HAIs and increasing need for waste...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆